Science & Innovation06.07.2021
People & Culture06.03.2021
In Mumbai, Vinod Mattoo got the virus and wondered if he’d survive. Una Krisnan’s aunt got it near Chennai and didn’t survive it as India feels the grip of a new wave of COVID-19 infections.
Candid Conversations is a video series featuring Amgen leaders addressing topics of Diversity, Inclusion and Belonging — issues at the intersection of the workplace and society.
LUMAKRAS™ is the first and only targeted treatment for patients with non-small cell lung cancer who carry the KRAS G12C mutation.
Check here for Amgen updates, Amgen product information, public health resources, and other pertinent information related to COVID-19.
Amgen is a pioneer in the science of using living cells to make biologic medicines.
Amgen’s medicines treat serious illnesses and typically address diseases with a limited number of treatment options.
Making a positive difference in the world is at the heart of what we do at Amgen—and it goes beyond making vital medicines.
Amgen is a pioneer in the science of using living cells to making biologic medicines, leading and guiding the biotech industry.
Encounter opportunities both new and undiscovered, as we embrace leading-edge technologies, invest in our talents, and maximize our potential.